Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS

Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno CPharmaceutics. 2021 Sep...

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles

JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NANOMEDICINES, REVIEWS

 Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi:...

Clinical considerations for the design of PROTACs in cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451....

A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J, Alonso-Moreno C, Molina-Alarcón M, Seguí P. Laryngoscope Investig Otolaryngol. 2022 Jan 18;7(1):283-290. doi:...

Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

Development of innovative biomedical materials, JOURNAL ARTICLES 2019, NANOMEDICINES

Niza E, Nieto-Jiménez C, Noblejas-López MDM, Bravo I, Castro-Osma JA, Cruz-Martínez F, Buchaca MMS, Posadas I, Canales-Vázquez J, Lara-Sanchez A, Hermida-Merino D, Solano E, Ocaña A, Alonso-Moreno C. Nanomaterials (Basel). 2019 Aug 27;9(9):1208. PMID: 31461998; PMCID:...

Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma

Development of innovative biomedical materials, JOURNAL ARTICLES 2020, NANOMEDICINES

Niza E, Castro-Osma JA, Posadas I, Alonso-Moreno C, Bravo I, Garzón A, Canales-Vázquez J, Ceña V, Lara-Sánchez A, Albaladejo J, Otero A. Pharm. 2019 Mar 10;558:110-119. Epub 2019 Jan 9. PMID: 30639216 doi:...